Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Regulatory News (INS)

  • There is currently no data for INS

Rule 8.3- Int Nuclear Sol

4 Apr 2007 16:21

RAB Capital plc04 April 2007 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION +-----------------------------------+-----------------------------------------------------+|Name of person dealing (Note 1) |RAB Capital plc || | |+-----------------------------------+-----------------------------------------------------+|Company dealt in |International Nuclear Solutions plc || | |+-----------------------------------+-----------------------------------------------------+|Class of relevant security to which|Ordinary shares ||the dealings being disclosed relate| ||(Note 2) | || | |+-----------------------------------+-----------------------------------------------------+|Date of dealing |3 April 2007 || | |+-----------------------------------+-----------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) +-----------------------------------+-------------------------+---------------------------+| | Long | Short || | | || | | |+-----------------------------------+-------------------------+---------------------------+| |Number (%) |Number (%) || | | || | | |+-----------------------------------+-------------------------+---------------------------+|(1) Relevant securities | | || | | || | | |+-----------------------------------+-------------------------+---------------------------+|(2) Derivatives (other than |658,200 (1.06%) | ||options) | | || | | || | | |+-----------------------------------+-------------------------+---------------------------+|(3) Options and agreements to | | ||purchase/sell | | || | | || | | |+-----------------------------------+-------------------------+---------------------------+|Total |658,200 (1.06%) | || | | || | | |+-----------------------------------+-------------------------+---------------------------+ (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) +-----------------------------------+-------------------------+---------------------------+|Class of relevant security: | Long | Short || | | || | | |+-----------------------------------+-------------------------+---------------------------+| |Number (%) |Number (%) || | | || | | |+-----------------------------------+-------------------------+---------------------------+|(1) Relevant securities | | || | | || | | |+-----------------------------------+-------------------------+---------------------------+|(2) Derivatives (other than | | ||options) | | || | | || | | |+-----------------------------------+-------------------------+---------------------------+|(3) Options and agreements to | | ||purchase/sell | | || | | || | | |+-----------------------------------+-------------------------+---------------------------+|Total | | || | | || | | |+-----------------------------------+-------------------------+---------------------------+ (c) Rights to subscribe (Note 3) +-----------------------------------+-----------------------------------------------------+|Class of relevant security: |Details || | || | |+-----------------------------------+-----------------------------------------------------+| | || | |+-----------------------------------+-----------------------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +-----------------------------+----------------------------+------------------------------+|Purchase/sale |Number of securities |Price per unit (Note 5) || | | || | | |+-----------------------------+----------------------------+------------------------------+| | | || | | || | | |+-----------------------------+----------------------------+------------------------------+ (b) Derivatives transactions (other than options) +----------------+-------------------+---------------------------+------------------------+|Product name, |Long/short (Note 6)|Number of securities (Note |Price per unit (Note 5) || | |7) | ||e.g. CFD | | | |+----------------+-------------------+---------------------------+------------------------+|CFD |Long |8,200 |GBP 0.6209 |+----------------+-------------------+---------------------------+------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +---------------+-------------+----------------+--------+-----------+--------+-------------+|Product name, |Writing, |Number of |Exercise|Type, e.g. |Expiry |Option money || |selling, |securities to | |American, | | ||e.g. call |purchasing, |which the option|price |European |date |paid/received||option |varying etc. |relates (Note 7)| |etc. | |per unit || | | | | | |(Note 5) || | | | | | | |+---------------+-------------+----------------+--------+-----------+--------+-------------+| | | | | | | |+---------------+-------------+----------------+--------+-----------+--------+-------------+ (ii) Exercising +-----------------------------+----------------------------+------------------------------+|Product name, e.g. call |Number of securities |Exercise price per unit (Note ||option | |5) || | | || | | |+-----------------------------+----------------------------+------------------------------+| | | || | | || | | |+-----------------------------+----------------------------+------------------------------+ (d) Other dealings (including new securities) (Note 4) +-----------------------------+----------------------------+------------------------------+|Nature of transaction (Note |Details |Price per unit (if applicable)||8) | |(Note 5) || | | || | | |+-----------------------------+----------------------------+------------------------------+| | | || | | || | | |+-----------------------------+----------------------------+------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +----------------------------------------------------------------------------------------+|Full details of any agreement, arrangement or understanding between the person ||disclosing and any other person relating to the voting rights of any relevant securities||under any option referred to on this form or relating to the voting rights or future ||acquisition or disposal of any relevant securities to which any derivative referred to ||on this form is referenced. If none, this should be stated. |+----------------------------------------------------------------------------------------+| || || || ||None |+----------------------------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) NO +--------------------------------------------------+---------------------------------------+|Date of disclosure |4 April 2007 || | |+--------------------------------------------------+---------------------------------------+|Contact name |Sophie Devignon || | |+--------------------------------------------------+---------------------------------------+|Telephone number |020 7389 7035 || | |+--------------------------------------------------+---------------------------------------+|If a connected EFM, name of offeree/offeror with |N/A ||which connected | |+--------------------------------------------------+---------------------------------------+|If a connected EFM, state nature of connection |N/A ||(Note 10) | || | |+--------------------------------------------------+---------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Oct 20233:20 pmRNSHolding(s) in Company
3rd Oct 20232:25 pmRNSForm 8.3 -INSTEM PLC
3rd Oct 20232:10 pmPRNForm 8.3 - Instem Plc
3rd Oct 202312:31 pmRNSForm 8.3 - Instem PLC
3rd Oct 202312:20 pmRNSForm 8.3 - Instem PLC amendment
3rd Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Instem plc
3rd Oct 202310:04 amRNSForm 8.3 - Instem Plc
2nd Oct 20232:53 pmRNSForm 8.3 - INSTEM PLC
2nd Oct 20232:37 pmGNWForm 8.3 - Instem Plc
2nd Oct 20231:50 pmRNSForm 8.3 - Instem PLC
2nd Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Instem plc
2nd Oct 20239:02 amRNSForm 8.5 (EPT/RI)
29th Sep 20232:59 pmGNWForm 8.3 - Instem PLC
29th Sep 20232:08 pmPRNForm 8.3 - Instem Plc
29th Sep 20232:04 pmGNWForm 8.3 - [Instem plc - 28 09 2023] - (CGAML)
29th Sep 202310:18 amRNSForm 8.5 (EPT/RI)
27th Sep 20235:28 pmRNSHolding(s) in Company
27th Sep 20233:27 pmRNSForm 8.3 - Instem PLC
27th Sep 20231:20 pmPRNForm 8.3 - Instem Plc
27th Sep 202310:03 amRNSForm 8.5 (EPT/RI)
27th Sep 20239:50 amRNSForm 8.3 - Instem Plc
26th Sep 202312:03 pmRNSForm 8.5 (EPT/RI)
25th Sep 20234:24 pmRNSPublication of Scheme Document
25th Sep 20233:27 pmRNSForm 8.3 - Instem PLC
25th Sep 20239:29 amRNSForm 8.3 - Instem Plc
25th Sep 20239:24 amRNSForm 8.5 (EPT/RI)
22nd Sep 202311:52 amRNSForm 8.5 (EPT/RI)
21st Sep 20231:07 pmRNSForm 8.3 - Instem plc
21st Sep 202311:51 amRNSForm 8.5 (EPT/RI)
20th Sep 202310:07 amRNSForm 8.5 (EPT/RI)
20th Sep 20239:00 amRNSForm 8.3 - Instem Plc
19th Sep 20237:00 amRNSGrant of PDMR Options
18th Sep 20233:27 pmRNSForm 8.3 - Instem PLC
18th Sep 202310:09 amRNSForm 8.5 (EPT/RI)
15th Sep 20232:11 pmPRNForm 8.3 - Instem Plc
15th Sep 202311:15 amRNSHalf-year Report
15th Sep 202310:52 amRNSForm 8.3 - Instem plc
15th Sep 202310:38 amRNSForm 8.5 (EPT/RI)
15th Sep 20239:40 amRNSForm 8.3 - Instem Plc
14th Sep 20231:31 pmGNWForm 8.3 - Instem PLC
14th Sep 202311:45 amRNSForm 8.5 (EPT/RI)
14th Sep 202310:12 amRNSForm 8.3 - Instem plc
13th Sep 20232:30 pmRNSForm 8.3 - Instem plc
13th Sep 20231:01 pmPRNForm 8.3 - Instem Plc
13th Sep 20239:04 amRNSForm 8.3 - Instem plc
12th Sep 20239:41 amRNSForm 8.5 (EPT/RI)
11th Sep 20234:30 pmRNSForm 8.3 - Instem plc
11th Sep 20239:32 amRNSForm 8.3 - Instem Plc
8th Sep 20233:00 pmBUSForm 8.3 - INS LN
8th Sep 20232:50 pmRNSForm 8.3 - Instem plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.